These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

286 related items for PubMed ID: 8524236

  • 1. Molecular mechanism of inhibition of estrogen-induced cathepsin D gene expression by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in MCF-7 cells.
    Krishnan V, Porter W, Santostefano M, Wang X, Safe S.
    Mol Cell Biol; 1995 Dec; 15(12):6710-9. PubMed ID: 8524236
    [Abstract] [Full Text] [Related]

  • 2. Estrogen receptor-Sp1 complexes mediate estrogen-induced cathepsin D gene expression in MCF-7 human breast cancer cells.
    Krishnan V, Wang X, Safe S.
    J Biol Chem; 1994 Jun 03; 269(22):15912-7. PubMed ID: 8195246
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of estrogen-induced activity by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in the MCF-7 human breast cancer and other cell lines transfected with vitellogenin A2 gene promoter constructs.
    Nodland KI, Wormke M, Safe S.
    Arch Biochem Biophys; 1997 Feb 01; 338(1):67-72. PubMed ID: 9015389
    [Abstract] [Full Text] [Related]

  • 4. Estrogen does not inhibit 2,3,7, 8-tetrachlorodibenzo-p-dioxin-mediated effects in MCF-7 and Hepa 1c1c7 cells.
    Hoivik D, Willett K, Wilson C, Safe S.
    J Biol Chem; 1997 Nov 28; 272(48):30270-4. PubMed ID: 9374512
    [Abstract] [Full Text] [Related]

  • 5. The aryl hydrocarbon receptor (AHR)/AHR nuclear translocator (ARNT) heterodimer interacts with naturally occurring estrogen response elements.
    Klinge CM, Bowers JL, Kulakosky PC, Kamboj KK, Swanson HI.
    Mol Cell Endocrinol; 1999 Nov 25; 157(1-2):105-19. PubMed ID: 10619402
    [Abstract] [Full Text] [Related]

  • 6. Cellular and molecular biology of aryl hydrocarbon (Ah) receptor-mediated gene expression.
    Safe S, Krishnan V.
    Arch Toxicol Suppl; 1995 Nov 25; 17():99-115. PubMed ID: 7786196
    [Abstract] [Full Text] [Related]

  • 7. Transcriptional activation of c-fos protooncogene by 17beta-estradiol: mechanism of aryl hydrocarbon receptor-mediated inhibition.
    Duan R, Porter W, Samudio I, Vyhlidal C, Kladde M, Safe S.
    Mol Endocrinol; 1999 Sep 25; 13(9):1511-21. PubMed ID: 10478842
    [Abstract] [Full Text] [Related]

  • 8. Estrogen-induced c-fos protooncogene expression in MCF-7 human breast cancer cells: role of estrogen receptor Sp1 complex formation.
    Duan R, Porter W, Safe S.
    Endocrinology; 1998 Apr 25; 139(4):1981-90. PubMed ID: 9528985
    [Abstract] [Full Text] [Related]

  • 9. Role of estrogen receptor/Sp1 complexes in estrogen-induced heat shock protein 27 gene expression.
    Porter W, Wang F, Wang W, Duan R, Safe S.
    Mol Endocrinol; 1996 Nov 25; 10(11):1371-8. PubMed ID: 8923463
    [Abstract] [Full Text] [Related]

  • 10. Potentiation of CYP1A1 gene expression in MCF-7 human breast cancer cells cotreated with 2,3,7,8-tetrachlorodibenzo-p-dioxin and 12-O-tetradecanoylphorbol-13-acetate.
    Moore M, Narasimhan TR, Steinberg MA, Wang X, Safe S.
    Arch Biochem Biophys; 1993 Sep 25; 305(2):483-8. PubMed ID: 8396892
    [Abstract] [Full Text] [Related]

  • 11. Transcriptional activation of cathepsin D gene expression by 17beta-estradiol: mechanism of aryl hydrocarbon receptor-mediated inhibition.
    Wang F, Samudio I, Safe S.
    Mol Cell Endocrinol; 2001 Feb 14; 172(1-2):91-103. PubMed ID: 11165043
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of estrogen-induced progesterone receptor in MCF-7 human breast cancer cells by aryl hydrocarbon (Ah) receptor agonists.
    Harper N, Wang X, Liu H, Safe S.
    Mol Cell Endocrinol; 1994 Aug 14; 104(1):47-55. PubMed ID: 7821706
    [Abstract] [Full Text] [Related]

  • 13. Characterization of the aryl hydrocarbon receptor and aryl hydrocarbon responsiveness in human ovarian carcinoma cell lines.
    Rowlands C, Krishnan V, Wang X, Santostefano M, Safe S, Miller WR, Langdon S.
    Cancer Res; 1993 Apr 15; 53(8):1802-7. PubMed ID: 8385571
    [Abstract] [Full Text] [Related]

  • 14. Antiestrogenic effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin on 17 beta-estradiol-induced pS2 expression.
    Zacharewski TR, Bondy KL, McDonell P, Wu ZF.
    Cancer Res; 1994 May 15; 54(10):2707-13. PubMed ID: 8168101
    [Abstract] [Full Text] [Related]

  • 15. Functional and physical interactions between the estrogen receptor Sp1 and nuclear aryl hydrocarbon receptor complexes.
    Wang F, Hoivik D, Pollenz R, Safe S.
    Nucleic Acids Res; 1998 Jun 15; 26(12):3044-52. PubMed ID: 9611253
    [Abstract] [Full Text] [Related]

  • 16. 2,3,7,8-Tetrachlorodibenzo-p-dioxin versus 3-methylcholanthrene: comparative studies of Ah receptor binding, transformation, and induction of CYP1A1.
    Riddick DS, Huang Y, Harper PA, Okey AB.
    J Biol Chem; 1994 Apr 22; 269(16):12118-28. PubMed ID: 8163516
    [Abstract] [Full Text] [Related]

  • 17. Interaction of 2,3,7,8-tetrachlorodibenzo-p-dioxin, 12-O-tetradecanoylphorbol-13-acetate (TPA) and 17 beta-estradiol in MCF-7 human breast cancer cells.
    Moore M, Narasimhan TR, Wang X, Krishnan V, Safe S, Williams HJ, Scott AI.
    J Steroid Biochem Mol Biol; 1993 Mar 22; 44(3):251-61. PubMed ID: 8384872
    [Abstract] [Full Text] [Related]

  • 18. Evidence for the mechanism of action of the 2,3,7,8-tetrachlorodibenzo-p-dioxin-mediated decrease of nuclear estrogen receptor levels in wild-type and mutant mouse Hepa 1c1c7 cells.
    Zacharewski T, Harris M, Safe S.
    Biochem Pharmacol; 1991 Jun 15; 41(12):1931-9. PubMed ID: 1645554
    [Abstract] [Full Text] [Related]

  • 19. Studies on the relationship between estrogen receptor content, glutathione S-transferase pi expression, and induction by 2,3,7,8-tetrachlorodibenzo-p-dioxin and drug resistance in human breast cancer cells.
    Hoivik D, Wilson C, Wang W, Willett K, Barhoumi R, Burghardt R, Safe S.
    Arch Biochem Biophys; 1997 Dec 01; 348(1):174-82. PubMed ID: 9390189
    [Abstract] [Full Text] [Related]

  • 20. Modulation of gene expression and endocrine response pathways by 2,3,7,8-tetrachlorodibenzo-p-dioxin and related compounds.
    Safe SH.
    Pharmacol Ther; 1995 Dec 01; 67(2):247-81. PubMed ID: 7494865
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.